Delayed cutaneous hypersensitivity in patients with prostatic adenocarcinoma

Area of Science:

• Immunology
• Oncology
• Urology

Background:

• Assessing cell-mediated immunity is crucial for understanding cancer progression.
• Prostate adenocarcinoma is a significant health concern requiring novel treatment strategies.

Purpose of the Study:

• To evaluate the cell-mediated immunocompetence in patients with prostate adenocarcinoma.
• To correlate immune status with the presence or absence of metastatic disease.

Main Methods:

• Utilized dinitrochlorobenzene (DNCB) as a contact sensitizing agent to assess immune response.
• Correlated immune status with clinical staging, specifically the presence of metastasis.

Main Results:

• A significant correlation was observed between a lack of immune response and the presence of metastatic prostate cancer.
• Patients with non-metastatic disease exhibited a more robust immune response.

Conclusions:

• Impaired cell-mediated immunity is strongly associated with metastatic prostate adenocarcinoma.
• Findings suggest immunotherapy holds promise for treating prostate cancer, especially in advanced, metastatic cases.